Mycenax Biotech Inc.

Mycenax (Stock code: 4726.TW)  is a CDMO (Contract Development and Manufacturing Organization) company that provides biopharmaceutical services and solutions for drug development and production, with customers in Taiwan, Japan, Korea, Singapore, among other Asia-Pacific regions, as well as Europe and the United States.
With a basis in the production of biosimilars and new biopharmaceuticals, since 2019 Mycenax has shifted to advancing technology platforms as well as building and expanding GMP plants to meet international standards, fulfilling the diverse needs of customers and providing tailor-made and streamlined CDMO services.